Rapid sequence induction in morbid obesity

The effect of the use of Vecuronium or Rocuronium as a rapid sequence induction for morbidly obese patients; A comparative Randomized Study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201804003260153

Enrollment

Registered

2018-03-28

Start date

2018-02-20

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Rapid sequence induction in morbid obese patients Anaesthesia

Interventions

Group (ROC)

Group (VEC)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -ASA II to III patients -Aged from 25 to 45 years old -Of both gender -With BMI > 40 kg/m2 ¿ 50 kg/m2 -Scheduled for elective surgeries

Exclusion criteria

Exclusion criteria: - Patient refusal to participate in research. - BMI 50kg/m2. - Pregnant or lactating patients - Known or suspected allergy to the used medication - Major cardiac, hepatic, renal, or pulmonary morbidities

Design outcomes

Primary

Measure	Time frame
The onset of intubation	—

Secondary

Measure	Time frame
The intubation score;The incidence of complications	—

Countries

Egypt

Contacts

Public ContactAhmed Elfayoumy

Secretary at the Faculty of Medicine

elfayoumi@hotmail.com00201094310605

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026